Cancer News and Research

Latest Cancer News and Research

Gustave Roussy and Biognosys Announce Partnership

The severe pneumonitis in patients infected by SARS-Cov-2 requires prolonged treatment in intensive care units with mechanical ventilation.

From Biognosys 28 Apr 2020

CNIC researchers develop mouse model to examine the mechanical function of proteins

The Molecular Mechanics of the Cardiovascular System group at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), led by Jorge Alegre Cebollada, in partnership with an international scientific team, has generated the first experimental mouse model that allows direct analysis of the mechanical function of proteins in living organisms.

28 Apr 2020

Scientists launch clinical trial to test the efficacy of HIV drug against COVID-19 infection

A team of scientists from St. Michael's Hospital, Sinai Health and Sunnybrook Health Sciences Centre have launched a clinical trial to understand whether an existing drug used for HIV treatment and prevention may work to prevent COVID-19 infection.

28 Apr 2020

New Leica platform adds an additional dimension of information to confocal imaging

Leica Microsystems, has announced the launch of its flagship new confocal microscopy platform, called STELLARIS.

From Leica Microsystems GmbH 28 Apr 2020

Study of nearly 10,000 women explores feasibility and safety of multi-cancer blood test

A study of nearly 10,000 women with no cancer history found that a multi-cancer blood test successfully detected some cancers.

28 Apr 2020

GRAIL to present new data at the American Association for Cancer Research (AACR) annual meeting

GRAIL, Inc., a healthcare company whose mission is to detect cancer early, today announced that new data for its investigational multi-cancer early detection blood test will be presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting I.

From GRAIL, Inc. 28 Apr 2020

A new tool for developing gene therapies against cancer, genetic disorders, and blood diseases

A UCLA-led research team today reports that it has developed a new method for delivering DNA into stem cells and immune cells safely, rapidly and economically.

28 Apr 2020

Researchers develop new method for remotely stimulating activity in deep brain regions

University of Texas at Dallas researchers have developed a promising method for remotely stimulating activity in deep brain regions, advancing understanding of how molecules act in the brain and paving the way for better cancer treatments and therapies for other diseases.

27 Apr 2020

Discovery of new type of immune cell in breast ducts

Australian researchers from Walter and Eliza Hall Institute have discovered a new form of immune cells within the ducts of the breast that keeps the breasts healthy. The study was published this week in the journal Nature Cell Biology.

27 Apr 2020

Scientists elucidate novel disease processes involved in pulmonary fibrosis development

Working alongside research groups from Heidelberg, researchers from Charité - Universitätsmedizin Berlin have elucidated the novel disease processes involved in the development of pulmonary fibrosis.

27 Apr 2020

Researchers report promising new therapy for recurrent pediatric brain cancers

Two pediatric brain cancers that are challenging to treat if they recur, medulloblastoma and ependymoma, are the target of a clinical trial using a new type of therapy.

27 Apr 2020

Simple blood test offers early warning of chemotherapy-related cardiac dysfunction

Scientists have identified a collection of biomarkers that together signal that a person's cancer treatment may be harming their heart.

27 Apr 2020

Cannabidiol could be a useful therapy for difficult-to-treat brain cancer

Findings from a new study examining human and canine brain cancer cells suggest that cannabidiol could be a useful therapy for a difficult-to-treat brain cancer. Cannabidiol, or CBD, is a non-psychoactive chemical compound derived from marijuana.

27 Apr 2020

Intensivists caution against the use of premature novel therapies for COVID-19

Intensivists caution against the use of premature novel therapies in lieu of traditional critical care principles in patients with COVID-19 in a recent correspondence letter in the American Journal of Respiratory Cell and Molecular Biology.

27 Apr 2020

Patients with aggressive form of skin cancer can benefit from new type of immunotherapy

In what is believed to be a first-of-its-kind study to evaluate the safety of a type of immunotherapy before surgery in patients with an aggressive form of skin cancer, researchers report that the treatment eliminated pathologic evidence of cancer in nearly half of the study participants undergoing surgery.

27 Apr 2020

Study can lead the way to new treatment methods for hepatitis C in infants

Only about five per cent of the babies born to mothers with hepatitis C are themselves infected by the disease.

27 Apr 2020

Investigational drug may hold benefit for patients with lung and ovarian cancers

In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1), researchers from The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division and Ipsen Biopharmaceuticals reported the preclinical discovery and early-stage clinical development of this novel drug. IPN60090, now under investigation in a Phase I trial, may hold benefit for certain patients with lung and ovarian cancers.

27 Apr 2020

Study: Combination of melanoma drugs prevents cancer from growing or spreading

A first-of-its-kind randomized clinical trial offers strong and perhaps surprising evidence that a combination of two targeted melanoma drugs when given continuously keeps patients' cancer from growing or spreading longer when compared with intermittent treatment, according to study results to be presented at the 2020 virtual annual meeting of the American Association for Cancer Research.

27 Apr 2020

Talazoparib did not show overall survival benefit in patients with advanced BRCA-mutated breast cancer

New data from the Phase III EMBRACA trial led by researchers at The University of Texas MD Anderson Cancer Center found the PARP inhibitor talazoparib did not demonstrate a statistically significant overall survival (OS) benefit for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.

27 Apr 2020

Researchers re-purpose cancer-fighting artificial antibodies for COVID-19

Researcher Paula Bates, John Trent, and Don Miller developed a therapeutic drug that could potentially block the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for the COVID-19 pandemic. Their research was initially aimed at helping patients suffering from multiple types of cancer.

27 Apr 2020

Cancer News and Research

Latest Cancer News and Research

Gustave Roussy and Biognosys Announce Partnership

CNIC researchers develop mouse model to examine the mechanical function of proteins

Scientists launch clinical trial to test the efficacy of HIV drug against COVID-19 infection

New Leica platform adds an additional dimension of information to confocal imaging

Study of nearly 10,000 women explores feasibility and safety of multi-cancer blood test

GRAIL to present new data at the American Association for Cancer Research (AACR) annual meeting

A new tool for developing gene therapies against cancer, genetic disorders, and blood diseases

Researchers develop new method for remotely stimulating activity in deep brain regions

Discovery of new type of immune cell in breast ducts

Scientists elucidate novel disease processes involved in pulmonary fibrosis development

Researchers report promising new therapy for recurrent pediatric brain cancers

Simple blood test offers early warning of chemotherapy-related cardiac dysfunction

Cannabidiol could be a useful therapy for difficult-to-treat brain cancer

Intensivists caution against the use of premature novel therapies for COVID-19

Patients with aggressive form of skin cancer can benefit from new type of immunotherapy

Study can lead the way to new treatment methods for hepatitis C in infants

Investigational drug may hold benefit for patients with lung and ovarian cancers

Study: Combination of melanoma drugs prevents cancer from growing or spreading

Talazoparib did not show overall survival benefit in patients with advanced BRCA-mutated breast cancer

Researchers re-purpose cancer-fighting artificial antibodies for COVID-19

Understanding the DNA Damage Response in Innate Immunity eBook

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Newsletters you may be interested in